Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Volume Reduction and Process Optimization with Cadence Inline Concentrator
Single-Use-Systems: Leachable Study Design for Single-Use Components
Kathryn McGohan,Scientist, Global Manufacturing Sciences & Technology organization at Bristol-Myers Squibb
View All Featured ArticlesHeadline News
Novo Nordisk’s once-weekly Sogroya receives positive CHMP opinion in Europe for children with idiopathic short stature
Lunsumio plus lenalidomide improves progression free survival in Phase III follicular lymphoma trial
Novo Nordisk’s CagriSema outperforms tirzepatide on weight loss in REIMAGINE 5 trial
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Pharmaceutical Manufacturing in the 21st Century-From Batch to Continuous Manufacturing-An FDA Perspective
Presented by Dr Sau (Larry) Lee, FDA
15th June 2016
Development and Implementation of Intensified Bioprocessing for Biologics Manufacturing
Presented by Hang Zhou, Ph.D., Vice President, Head of Cell Culture Process Development Biologics and Bioprocess Dept. at WuXi Biologics
12th March 2021
Transformational Science: Moving from Challenges of High Concentration Protein Formulations Development to Meet the Needs of High Potent Bispecifics
Presented by Sachin Dubey, Ph.D., Head of Formulation and Analytical Development at Glenmark Pharmaceuticals SA
19th March 2019
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Push-Button Simplicity: Automatic Fermentation with the BioFlo® 120 Auto Culture Mode
Rationale Design of Valves for Flexible Processing
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
